Fig. 4
Cytokeratin 18 (CK18) immunostaining and patient prognosis. All bladder cancer patients had at least pT2 cancers and were treated by cystectomy
Fig. 4 | Molecular Medicine
Cytokeratin 18 (CK18) immunostaining and patient prognosis. All bladder cancer patients had at least pT2 cancers and were treated by cystectomy
Molecular Medicine